Effect of Vitamin D Supplementation on Coronary Calcification and Parathyroid Hormone in CKD Patients

• Status: Unknown status
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators hypothesize that the chronic kidney disease patients who suffer from vitamin D deficiency will be benefit from given Vitamin D2 because coronary artery calcification and hyperparathyroidism will be improved.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Peking University People's Hospital
• Treatments: Ergocalciferols; Hormones; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• chronic kidney disease patients (3-5D)

• serum 25（OH）D < 40nmol/L(16ng/ml)，serum calcium < 2.55mmol/L（10.2mg/dL）；

• willing to sign

• could obey the follow up design

Exclusion Criteria:

• allergy to vitamin D

• heart failure (NYHA more than 2 grade)

• pregnant

• malignant tumor

• critical hepatic disease

• taking Vitamin D or analogue in 3 recent months

• taking other clinical trial